Skip to main content

Imran Talat's Form 4 filing

Rani Therapeutics Holdings, Inc. (RANI) · filed Jul 21, 2026

Accession no.
0001869579-26-000006
Filed
Jul 21, 2026, 6:25 PM ET
Trade date
Dec 27, 2024-Jun 27, 2026
Filing delay
571 daysLate
Rule 10b5-1 plan
Not checked

This filing lists 7 non-derivative transactions. Open-market sales total $11.3K. It was filed 571 days after the trade, past the 2-business-day deadline.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Imran TalatCIK 0001869579Director, Officer (Chief Executive Officer)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Dec 27, 2024Class A Common StockSSaleDisposed−8,014$1.41−$11,299.74486,737Direct
Jun 27, 2025Class A Common StockFTax withholdingDisposed−9,076$0.55−$4,991.8477,661Direct
Sep 27, 2025Class A Common StockFTax withholdingDisposed−9,077$0.48−$4,356.96468,584Direct
Dec 27, 2025Class A Common StockFTax withholdingDisposed−7,906$1.40−$11,068.4460,678Direct
Mar 22, 2026Class A Common StockFTax withholdingDisposed−8,916$1.13−$10,075.08451,762Direct
Mar 27, 2026Class A Common StockFTax withholdingDisposed−9,099$0.81−$7,370.19442,663Direct
Jun 27, 2026Class A Common StockFTax withholdingDisposed−7,927$0.74−$5,865.98434,736Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

No transaction price on this filing refers to a footnote.

Read the full filing on SEC EDGAR (opens in a new tab)